vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and Sachem Capital Corp. (SACH). Click either name above to swap in a different company.
Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $12.0M, roughly 1.1× Sachem Capital Corp.). Sachem Capital Corp. runs the higher net margin — 8.3% vs -342.3%, a 350.6% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs -18.8%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Sachem Capital Corp.SACHEarnings & Financial Report
Sachem Head Capital Management is an American value-oriented investment management firm based in New York City, managed by Scott Ferguson.
GOSS vs SACH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $12.0M |
| Net Profit | $-47.2M | $997.0K |
| Gross Margin | — | — |
| Operating Margin | -333.6% | -3.1% |
| Net Margin | -342.3% | 8.3% |
| Revenue YoY | 47.1% | -18.8% |
| Net Profit YoY | -43.0% | 119.7% |
| EPS (diluted) | $-0.21 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | — | ||
| Q3 25 | $13.3M | $12.0M | ||
| Q2 25 | — | $10.8M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $10.8M | ||
| Q3 24 | — | $14.8M | ||
| Q2 24 | $95.8M | $15.1M | ||
| Q1 24 | $0 | $16.8M |
| Q4 25 | $-47.2M | — | ||
| Q3 25 | $-48.2M | $997.0K | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $904.0K | ||
| Q4 24 | — | $-36.1M | ||
| Q3 24 | — | $-5.1M | ||
| Q2 24 | $49.2M | $-3.1M | ||
| Q1 24 | $-41.9M | $4.7M |
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | -3.1% | ||
| Q2 25 | — | 9.9% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | -131.1% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | 54.3% | -20.6% | ||
| Q1 24 | — | 25.4% |
| Q4 25 | -342.3% | — | ||
| Q3 25 | -362.7% | 8.3% | ||
| Q2 25 | — | 17.5% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | -335.6% | ||
| Q3 24 | — | -34.2% | ||
| Q2 24 | 51.4% | -20.2% | ||
| Q1 24 | — | 27.8% |
| Q4 25 | $-0.21 | — | ||
| Q3 25 | $-0.21 | $0.00 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $-0.79 | ||
| Q3 24 | — | $-0.13 | ||
| Q2 24 | $0.22 | $-0.09 | ||
| Q1 24 | $-0.19 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $12.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $175.6M |
| Total Assets | $172.2M | $484.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | — | ||
| Q3 25 | $180.2M | $12.6M | ||
| Q2 25 | — | $23.5M | ||
| Q1 25 | — | $25.8M | ||
| Q4 24 | — | $19.6M | ||
| Q3 24 | — | $7.4M | ||
| Q2 24 | $354.5M | $12.4M | ||
| Q1 24 | $244.4M | $56.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $230.2M | ||
| Q4 24 | — | $230.2M | ||
| Q3 24 | — | $264.7M | ||
| Q2 24 | — | $264.7M | ||
| Q1 24 | — | $288.4M |
| Q4 25 | $-122.8M | — | ||
| Q3 25 | $-82.3M | $175.6M | ||
| Q2 25 | — | $177.9M | ||
| Q1 25 | — | $179.3M | ||
| Q4 24 | — | $181.7M | ||
| Q3 24 | — | $220.6M | ||
| Q2 24 | $81.5M | $230.2M | ||
| Q1 24 | $26.7M | $237.4M |
| Q4 25 | $172.2M | — | ||
| Q3 25 | $208.8M | $484.4M | ||
| Q2 25 | — | $501.8M | ||
| Q1 25 | — | $491.4M | ||
| Q4 24 | — | $492.0M | ||
| Q3 24 | — | $555.5M | ||
| Q2 24 | $373.4M | $586.3M | ||
| Q1 24 | $259.4M | $626.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.28× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.15× | ||
| Q1 24 | — | 1.21× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $4.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 4.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | — | ||
| Q3 25 | $-36.2M | $4.9M | ||
| Q2 25 | — | $501.0K | ||
| Q1 25 | — | $191.0K | ||
| Q4 24 | — | $12.9M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | $116.3M | $7.0M | ||
| Q1 24 | $-52.3M | $4.2M |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.95× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
